Labeler · US market

AstraZeneca AB

AstraZeneca AB is a US drug labeler with US FDA registrations covering 20 drug concepts (20 currently active) across 41 packages. It is currently the only active US supplier of 7 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes17228

Active drugs20

Registrations39 active / 39

Packages41

Sole supplier of7 drugs

Portfolio20 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Metoprolol Succinate tablet, extended release	other	4	4	SUPPLYING
Candesartan Cilexetil tablet	other	4	4	SUPPLYING
Durvalumab injection, solution	rx	2	4	SUPPLYING
Candesartan Cilexetil Hydrochlorothiazide tablet	other	3	3	SUPPLYING
Osimertinib tablet, film coated	other	2	2	SUPPLYING
Esomeprazole Magnesium capsule	other	2	2	SUPPLYING
Selumetinib capsule	other	2	2	SUPPLYING
Olaparib tablet, film coated	other	2	2	SUPPLYING
Omeprazole Magnesium tablet, delayed release	other	2	2	SUPPLYING
Dapagliflozin tablet, film coated	other	2	2	SUPPLYING
Ticagrelor tablet, film coated	other	2	2	SUPPLYING
Capivasertib tablet, film coated	other	2	2	SUPPLYING
Baxdrostat tablet, film coated	other	2	2	SUPPLYING
Micronized Glycopyrronium Bromide powder	other	2	2	SUPPLYING
Benralizumab injection, solution	rx	1	1	SUPPLYING
Budesonide Micronized powder	other	1	1	SUPPLYING
Albuterol Sulfate Micronised Conditioned powder	other	1	1	SUPPLYING
Ticagrelor powder	other	1	1	SUPPLYING
Acalabrutinib tablet, film coated	other	1	1	SUPPLYING
Budesonide Micronised Co-Suspension Apn powder	other	1	1	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

Albuterol Sulfate Micronised Conditionedother
Baxdrostatother
Budesonide Micronised Co-Suspension Apnother
Candesartan Cilexetilother
Candesartan Cilexetil Hydrochlorothiazideother
Capivasertibother
Ticagrelorother

At a glance

TypeLabeler
Labeler codes17228
Filing names1
Drugs (active)20
Drugs (all time)20
US registrations39
Packages41

Recent events

Shortages, recalls, and registration changes across all filing names.

Oct 27, 2025
RESOLVEDShortage resolved: Pramlintide Acetate Injection (AstraZeneca AB)
Oct 27, 2025
SHORTAGEDrug shortage: Pramlintide Acetate Injection (AstraZeneca AB)

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.